APA (7th ed.) Citation

JH, B., YJ, L., JB, P., JE, B., SW, H., SH, P., . . . SW, H. (2025). Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study. Therapeutic advances in gastroenterology, 18, 17562848251333516. https://doi.org/10.1177/17562848251333516

Chicago Style (17th ed.) Citation

JH, Bae, et al. "Comparative Efficacy of Subcutaneous Infliximab Switching in Remission and Non-remission Patients with Inflammatory Bowel Disease After Intravenous Maintenance: 1-year Outcome from a Multicentre Cohort Study." Therapeutic Advances in Gastroenterology 18 (2025): 17562848251333516. https://doi.org/10.1177/17562848251333516.

MLA (9th ed.) Citation

JH, Bae, et al. "Comparative Efficacy of Subcutaneous Infliximab Switching in Remission and Non-remission Patients with Inflammatory Bowel Disease After Intravenous Maintenance: 1-year Outcome from a Multicentre Cohort Study." Therapeutic Advances in Gastroenterology, vol. 18, 2025, p. 17562848251333516, https://doi.org/10.1177/17562848251333516.